bf/NASDAQ:TRIB_icon.jpeg

COM:TRINITYBIOTECH

Trinity Biotech plc

  • Stock

Last Close

1.67

07/11 21:00

Market Cap

18.83M

Beta: -

Volume Today

31.96K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
25.21M
-
31.59M
25.30%
34.32M
8.63%
33.86M
1.35%
32.70M
3.43%
31.58M
3.41%
31.19M
1.24%
31.12M
0.22%
29.67M
4.66%
25.81M
13.00%
21.22M
17.80%
average payables
16.48M
-
20.66M
25.40%
20.04M
3.04%
21.95M
9.56%
22.94M
4.49%
19.09M
16.75%
18.35M
3.91%
13.23M
27.91%
6.93M
47.58%
11.91M
71.74%
15.77M
32.47%
average receivables
19.77M
-
25.59M
29.43%
26.29M
2.73%
24.97M
5.02%
22.99M
7.95%
24.10M
4.86%
24.50M
1.64%
23.78M
2.92%
20.15M
15.26%
16.65M
17.39%
16.50M
0.88%
book value per share
8.34
-
8.66
3.78%
9.23
6.65%
4.73
48.73%
3.02
36.31%
2.11
30.11%
0.23
89.30%
-0.11
147.08%
-0.02
85.62%
-0.06
274.14%
-15.64
27,294.68%
capex per share
-1.00
-
-1.05
5.18%
-0.98
6.79%
-0.97
1.09%
-0.76
21.97%
-0.83
9.24%
-0.73
11.16%
-0.49
33.59%
-0.42
14.78%
-0.16
62.28%
-1.77
1,026.06%
capex to depreciation
-6.11
-
-5.33
12.88%
-4.03
24.39%
-3.63
9.77%
-3.15
13.34%
-4.19
33.24%
-3.14
25.20%
-3.31
5.63%
-3.17
4.44%
-2.56
19.11%
-1.52
40.60%
capex to operating cash flow
-1.87
-
-1.52
18.94%
-1.84
21.19%
-1.62
12.16%
-1.35
16.47%
-2.49
84.46%
-2.81
12.54%
-0.43
84.70%
-0.66
52.93%
6.49
1,088.50%
0.14
97.83%
capex to revenue
-0.24
-
-0.23
5.13%
-0.23
0.67%
-0.22
1.36%
-0.17
26.18%
-0.18
7.91%
-0.17
4.69%
-0.10
41.10%
-0.09
6.51%
-0.08
14.50%
-0.05
40.47%
cash per share
1.02
-
0.40
60.67%
4.40
1,000.19%
3.36
23.72%
4.24
26.24%
1.45
65.83%
0.84
41.97%
1.31
55.54%
1.24
5.19%
0.17
86.07%
2.41
1,296.65%
days of inventory on hand
239.04
-
224.37
6.13%
237.64
5.91%
210.46
11.44%
209.15
0.63%
199.35
4.68%
223.41
12.07%
206.55
7.55%
193.67
6.24%
155.76
19.57%
189.82
21.87%
days payables outstanding
162.19
-
141.89
12.51%
127.69
10.01%
161.63
26.58%
132.90
17.78%
113.89
14.30%
135.01
18.55%
48.55
64.04%
44.97
7.37%
118.03
162.44%
138.05
16.96%
days sales outstanding
99.06
-
91.99
7.13%
95.27
3.56%
87.18
8.49%
81.66
6.33%
97.89
19.88%
92.70
5.30%
88.03
5.04%
61.68
29.93%
85.84
39.17%
99.01
15.34%
debt to assets
-0.05
-
-0.05
6.35%
0.27
653.06%
0.39
41.55%
0.49
27.46%
0.54
9.80%
0.64
18.72%
0.80
24.22%
0.83
4.23%
0.63
24.16%
0.92
45.93%
debt to equity
-0.07
-
-0.06
6.71%
0.46
852.88%
0.89
93.62%
1.46
64.04%
1.86
27.59%
17.91
861.77%
-47.02
362.48%
-310.84
561.05%
-26.77
91.39%
-2.29
91.44%
dividend yield
0.01
-
0.01
59.24%
0.02
48.25%
0.03
73.96%
earnings yield
0.02
-
0.04
130.53%
0.08
85.18%
-0.63
891.31%
-0.36
43.22%
0.05
113.89%
-0.19
477.02%
-0.08
59.89%
0.03
138.77%
-1.09
3,812.51%
-7.30
571.38%
enterprise value
529.17M
-
389.25M
26.44%
268.47M
31.03%
178.30M
33.59%
149.22M
16.31%
99.21M
33.51%
87.22M
12.08%
156.65M
79.59%
103.14M
34.16%
89.41M
13.31%
54.46M
39.08%
enterprise value over ebitda
27.60
-
21.46
22.23%
10.18
52.55%
17.97
76.47%
23.74
32.07%
13.37
43.66%
15.13
13.11%
7.06
53.32%
6.49
8.13%
-10.80
266.50%
-3.81
64.75%
ev to operating cash flow
45.21
-
24.71
45.34%
21.77
11.92%
12.95
40.51%
12.32
4.85%
14.31
16.12%
15.93
11.38%
6.59
58.62%
7.79
18.15%
-97.07
1,345.99%
-2.84
97.07%
ev to sales
5.80
-
3.71
36.02%
2.68
27.81%
1.79
33.20%
1.51
15.91%
1.02
32.07%
0.96
5.67%
1.54
59.26%
1.11
27.78%
1.20
7.77%
0.96
19.85%
free cash flow per share
-0.47
-
-0.36
22.92%
-0.45
24.57%
-0.37
17.36%
-0.20
46.87%
-0.50
151.63%
-0.47
4.53%
0.65
237.20%
0.22
66.46%
-0.18
183.21%
-14.29
7,796.26%
free cash flow yield
-0.02
-
-0.02
10.67%
-0.04
85.48%
-0.05
40.44%
-0.04
29.02%
-0.22
469.18%
-0.46
111.55%
0.17
137.21%
0.15
10.64%
-0.18
220.19%
-6.65
3,535.95%
graham net net
0.56
-
-0.01
101.43%
-0.26
3,119.75%
-1.29
402.79%
-0.13
90.21%
-2.02
1,498.25%
-3.61
79.02%
-3.43
5.05%
-3.20
6.65%
-1.66
48.18%
-37.99
2,188.54%
graham number
9.40
-
12.14
29.09%
13.98
15.17%
21.60
54.51%
11.24
47.97%
2.33
79.29%
0.99
57.33%
0.83
16.56%
0.12
85.54%
1.18
880.63%
74.31
6,220.01%
income quality
0.59
-
0.72
20.74%
0.62
13.12%
0.85
36.44%
0.95
11.90%
0.53
44.09%
0.45
15.39%
-3.72
928.66%
15.13
506.84%
0.02
99.85%
0.52
2,216.31%
intangibles to total assets
0.57
-
0.60
5.22%
0.45
24.75%
0.35
22.20%
0.34
3.86%
0.35
4.15%
0.33
4.87%
0.26
22.03%
0.30
16.54%
0.38
26.53%
0.27
28.51%
interest coverage
238.31
-
261.43
9.71%
3.86
98.52%
1.59
58.95%
1.17
26.19%
0.75
35.83%
0.18
76.51%
3.45
1,857.50%
2.41
30.19%
-0.44
118.30%
-1.45
229.90%
interest debt per share
-0.54
-
-0.53
3.13%
4.40
936.22%
4.42
0.55%
4.62
4.51%
4.14
10.46%
4.28
3.39%
5.26
22.94%
5.01
4.79%
2.18
56.48%
43.05
1,876.64%
inventory turnover
1.53
-
1.63
6.54%
1.54
5.58%
1.73
12.91%
1.75
0.63%
1.83
4.91%
1.63
10.77%
1.77
8.16%
1.88
6.65%
2.34
24.33%
1.92
17.94%
invested capital
-0.07
-
-0.06
6.71%
0.46
852.88%
0.89
93.62%
1.46
64.04%
1.86
27.59%
17.91
861.77%
-47.02
362.48%
-310.84
561.05%
-26.77
91.39%
-2.29
91.44%
market cap
551.49M
-
398.35M
27.77%
272.38M
31.62%
158.92M
41.66%
112.00M
29.52%
47.87M
57.26%
21.60M
54.88%
79.64M
268.69%
29.89M
62.47%
37.73M
26.22%
3.29M
91.27%
net current asset value
33.27M
-
23.18M
30.31%
18.16M
21.68%
-7.38M
140.62%
-14.83M
100.99%
-20.52M
38.40%
-54.97M
167.88%
-49.32M
10.28%
-46.53M
5.66%
-47.61M
2.33%
-44.34M
6.87%
net debt to ebitda
-1.16
-
-0.50
56.88%
-0.15
70.45%
1.95
1,417.62%
5.92
203.02%
6.92
16.90%
11.38
64.44%
3.47
69.50%
4.61
32.71%
-6.24
235.52%
-3.58
42.70%
net income per share
0.47
-
0.76
60.57%
0.94
24.37%
-4.38
565.63%
-1.86
57.49%
0.11
106.14%
-0.19
270.14%
-0.29
47.88%
0.04
114.55%
-1.08
2,670.20%
-15.69
1,358.04%
operating cash flow per share
0.53
-
0.69
29.75%
0.53
23.09%
0.60
12.60%
0.56
6.58%
0.33
40.77%
0.26
21.06%
1.14
333.96%
0.63
44.27%
-0.02
103.82%
-12.53
51,732.73%
payables turnover
2.25
-
2.57
14.30%
2.86
11.12%
2.26
21.00%
2.75
21.62%
3.20
16.69%
2.70
15.65%
7.52
178.08%
8.12
7.95%
3.09
61.90%
2.64
14.50%
receivables turnover
3.68
-
3.97
7.68%
3.83
3.44%
4.19
9.28%
4.47
6.76%
3.73
16.58%
3.94
5.60%
4.15
5.31%
5.92
42.72%
4.25
28.15%
3.69
13.30%
research and ddevelopement to revenue
0.04
-
0.04
1.09%
0.05
23.65%
0.05
0.05%
0.06
12.77%
0.06
3.05%
0.06
6.42%
0.05
15.40%
0.05
2.89%
0.06
14.40%
0.08
39.24%
return on tangible assets
0.11
-
0.18
66.73%
0.11
37.33%
-0.62
662.13%
-0.31
49.20%
0.02
107.72%
-0.05
291.27%
-0.06
33.91%
0.01
116.94%
-0.72
6,936.11%
-0.56
22.87%
revenue per share
4.16
-
4.61
10.86%
4.33
6.16%
4.34
0.27%
4.59
5.71%
4.64
1.24%
4.33
6.79%
4.88
12.77%
4.45
8.84%
1.96
55.88%
37.12
1,791.69%
roe
0.06
-
0.09
54.71%
0.10
16.61%
-0.93
1,008.20%
-0.62
33.26%
0.05
108.78%
-0.86
1,690.22%
2.71
414.10%
-2.74
201.22%
18.84
786.96%
1.00
94.68%
roic
0.10
-
0.09
4.63%
0.04
56.02%
0.04
11.94%
0.05
35.40%
0.02
57.96%
-0.04
292.89%
0.14
462.66%
0.14
0.99%
-0.16
209.33%
-0.52
234.83%
sales general and administrative to revenue
0.27
-
0.27
0.56%
0.28
3.10%
0.31
10.58%
0.31
0.65%
0.30
2.32%
0.31
0.33%
0.25
19.39%
0.27
7.99%
shareholders equity per share
8.34
-
8.66
3.78%
9.23
6.65%
4.73
48.73%
3.02
36.31%
2.11
30.11%
0.23
89.30%
-0.11
147.08%
-0.02
85.62%
-0.06
274.14%
-15.64
27,294.68%
stock based compensation to revenue
0.02
-
0.01
35.39%
0.02
8.44%
0.01
8.24%
0.01
34.06%
0.01
50.72%
0.01
40.59%
0.01
7.34%
0.01
52.36%
0.02
98.46%
tangible asset value
54.46M
-
51.95M
4.61%
52.56M
1.18%
21.45M
59.19%
442K
97.94%
-8.90M
2,112.90%
-38.94M
337.69%
-36.08M
7.35%
-36.30M
0.61%
-37.45M
3.15%
-40.22M
7.41%
tangible book value per share
2.48
-
2.28
8.02%
2.27
0.68%
0.93
58.81%
0.02
97.81%
-0.43
2,182.07%
-1.86
337.72%
-1.73
7.35%
-1.74
0.61%
-0.98
43.42%
-15.64
1,491.96%
working capital
55.77M
-
46.99M
15.73%
143.12M
204.55%
108.21M
24.39%
91.36M
15.57%
69.06M
24.41%
51.94M
24.79%
56.24M
8.28%
-27.80M
149.43%
29.33M
205.49%
24.01M
18.15%

All numbers in (except ratios and percentages)